POLARGO: A randomized phase III study evaluating polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma who had received one or more previous therapies Meeting Abstract
| Authors: | McMillan, A. K.; Matasar, M. J.; Sancho, J. M.; Viardot, A.; Hernandez, J.; Perretti, T.; Haioun, C. |
| Abstract Title: | POLARGO: A randomized phase III study evaluating polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma who had received one or more previous therapies |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164606036 |
| DOI: | 10.1182/blood-2019-123673 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5317 -- Source: Wos |
